Journal article
1121P Costs of dacomitinib versus placebo in pretreated unselected patients (pts) with advanced NSCLC: CCTG BR.26
Authors
Karim S; Ding K; Bradbury P; Ellis P; Mittman N; Sun XX; Millward M; Liu G; Sun S; Stockler MR
Journal
Annals of Oncology, Vol. 28, ,
Publisher
Elsevier
Publication Date
September 1, 2017
DOI
10.1093/annonc/mdx375.009
ISSN
0923-7534